glp 1 drug history Reflections on the discovery GLP-1 as a satiety hormone: Implications for obesity therapy and future directions Mapping the effectiveness and risks

The observation that DPP4 might be involved in the immune-regulatory system was also investigated in DPP4-KO mice, which were treated with pokeweed mitogen that stimulates growth and proliferation of B-cells

"It's a worthwhile discussion for the patient and provider to really think about what is going to help them stay on the medication longer," says Watanabe

doi: 10.1093/brain/aws059 213 ZhangR

Type 2 diabetes with cardiovascular risk Injectable semaglutide has direct cardiovascular outcome data in patients with established cardiovascular disease and overweight or obesity, from the SELECT trial

If you can improve the way youre using glucose in your body and brain, you wont trigger neuroinflammation, which accelerates damage to the neurons. Alzheimers is now unofficially known as type 3 diabetes, explains clinical pharmacist James LaValle, RPh, CCN, MT, Life Times chief science officer

To understand how these medications work, you first need to know about the GLP-1 hormone your own body produces